Law Office of Brodsky & Smith, LLC Announces Class Action Lawsuit Against Life Sciences Research, Inc.
10 Julio 2009 - 3:11PM
Marketwired
Law office of Brodsky & Smith, LLC announces that a class
action lawsuit has been filed in the Superior Court of New Jersey
against Life Sciences Research, Inc. ("Life Sciences Research" or
the "Company") (NYSE: LSR) and the Company's Board of Directors
challenging the proposed acquisition of the Company by Lion
Holdings, Inc. ("Lion Holdings"). Andrew Baker, CEO of Life
Sciences Research, is the controlling member of Lion Holdings and
currently owns more than 17% of the outstanding stock of Life
Sciences Research.
Under the proposed agreement, Life Sciences Research
shareholders will receive $8.50 in cash for each share they own.
The deal is valued at approximately $113 million. Throughout 2008,
Life Sciences Research traded at significantly above the offer
price. As recently as October 2008 it was trading above $35.00 a
share and was still trading above $10.00 a share in December
2008.
If you own shares of Life Sciences Research and wish to discuss
the legal ramifications of the proposed acquisition by Lion
Holdings, or have any questions, you may e-mail or call the law
office of Brodsky & Smith, LLC who will, without obligation or
cost to you, attempt to answer your questions. You may contact
Jason L. Brodsky, Esquire or Marc Ackerman, Esquire at Brodsky
& Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004,
by e-mail at clients@brodsky-smith.com, or by calling toll free
877-LEGAL-90.
Jason L. Brodsky, Esquire Marc Ackerman, Esquire Brodsky &
Smith, LLC Email Contact 877-LEGAL-90
Life Sciences Research (NYSE:LSR)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Life Sciences Research (NYSE:LSR)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
Real-Time news about Life Sciences Research (New York Stock Exchange): 0 recent articles
Más de Brodsky & amp; Smith, LLC Artículos de Noticias